{"mainPropery":{"diseaseId":8604,"diseaseName":"Acanthoma","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/8604/acanthoma","synonyms":[],"synonyms-with-source":[],"identifiers":[{"identifierType":"UMLS","identifierId":"C0846967"}]},"diseaseCategories":[],"organizations":[],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=PureSearch&db=PubMed&details_term=%28%28%28%28acanthoma%5BTitle%5D%20AND%20hasabstract%5Btext%5D%29%20AND%20English%5BLang%5D%29%20AND%20%28%28%22human%22%5BMeSH%20Terms%5D%20OR%20%22hominidae%22%5BMeSH%20Terms%5D%29%20OR%20%22Human%22%5BMeSH%20Terms%5D%29%29%20AND%20%28%221992/11/22%2015.12%22%5BEDat%5D%20%3A%20%222002/11/20%2015.12%22%5BEDat%5D%29%29' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Acanthoma. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:174' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":6082,"questionText":"What is an acanthoma?","answerText":"<strong>An acanthoma </strong>is a small, reddish bump that usually develops on the skin of an older&nbsp;adult.&nbsp; There are several types of acanthoma,&nbsp;including \"acantholytic\", \"epidermolytic\", \"clear cell\", and \"melanoacanthoma\".[5110]&nbsp; Though most individuals have only one acanthoma, there have been rare reports of individuals who have developed many.&nbsp; The exact cause of acanthoma is not known; it is sometimes called a <a href=\"http://www.cancer.gov/dictionary?CdrID=46079\" target=_blank>benign tumor</a>,&nbsp;and sometimes described as&nbsp;the result of <a href=\"http://www.cancer.gov/dictionary?CdrID=44042\" target=_blank>inflammation</a>.&nbsp; Acanthomas are not considered dangerous and do not require treatment, but they may be removed for cosmetic reasons or to relieve any associated symptoms.[5109][5111]","dateModified":"2012-03-26T23:07:00"},"basicQuestions":[{"questionId":6083,"questionText":"How might an acanthoma be treated?","answerText":"Acanthomas are considered <a href=\"http://www.merriam-webster.com/medlineplus/benign\" target=_blank>benign</a>, but treatment may be done for cosmetic reasons or to relieve any associated symptoms.[5109][5111]&nbsp; Because acanthomas are quite rare, there are no established guidelines for treatment.&nbsp; Treatment may&nbsp;depend on the type, number, and location of acanthomas.&nbsp;&nbsp;For example,&nbsp;a single acanthoma&nbsp;may be&nbsp;removed by surgery, whereas multiple acanthomas may be treated with <a href=\"http://www.merriam-webster.com/medlineplus/cryosurgery\" target=_blank>cryosurgery</a> or the use of the medication <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a605010.html\" target=_blank>fluorouracil</a> cream.[5109]","dateModified":"2012-03-26T23:06:00","resourceClassificationName":"Treatment","references":[{"referenceId":5109,"authors":"Monari P, Farisoglio C, Gualdi G, Botali G, Ungari M, Calzavara-Pinton P","articleTitle":"Multiple eruptive clear cell acanthoma","bookWebsiteJournalTitle":"Journal of dermatological case reports","date":"2010","volume":"4","pages":"25-27","url":"http://www.ncbi.nlm.nih.gov/pubmed/21886743","dateAccessed":"2012-03-26T00:00:00"},{"referenceId":5111,"authors":"Andrews BT, Trask DK","articleTitle":"Oral melanoacanthoma: a case report, a review of the literature, and a new treatment option","bookWebsiteJournalTitle":"The Annals of otology, rhinology, and laryngology","date":"2005","volume":"114","pages":"677-680","url":"http://www.ncbi.nlm.nih.gov/pubmed/16240929#","dateAccessed":"2012-03-26T00:00:00"}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":34468,"abbreviatedInquiry":"I recently had a&nbsp;biopsy which showed an acanthoma.&nbsp; I am seeking information about this condition.","caseQuestions":[{"questionId":6082,"questionText":"What is an acanthoma?","answerText":"<strong>An acanthoma </strong>is a small, reddish bump that usually develops on the skin of an older&nbsp;adult.&nbsp; There are several types of acanthoma,&nbsp;including \"acantholytic\", \"epidermolytic\", \"clear cell\", and \"melanoacanthoma\".[5110]&nbsp; Though most individuals have only one acanthoma, there have been rare reports of individuals who have developed many.&nbsp; The exact cause of acanthoma is not known; it is sometimes called a <a href=\"http://www.cancer.gov/dictionary?CdrID=46079\" target=_blank>benign tumor</a>,&nbsp;and sometimes described as&nbsp;the result of <a href=\"http://www.cancer.gov/dictionary?CdrID=44042\" target=_blank>inflammation</a>.&nbsp; Acanthomas are not considered dangerous and do not require treatment, but they may be removed for cosmetic reasons or to relieve any associated symptoms.[5109][5111]","dateModified":"2012-03-26T23:07:00","references":[{"referenceId":5109,"authors":"Monari P, Farisoglio C, Gualdi G, Botali G, Ungari M, Calzavara-Pinton P","articleTitle":"Multiple eruptive clear cell acanthoma","bookWebsiteJournalTitle":"Journal of dermatological case reports","date":"2010","volume":"4","pages":"25-27","url":"http://www.ncbi.nlm.nih.gov/pubmed/21886743","dateAccessed":"2012-03-26T00:00:00"},{"referenceId":5110,"authors":"Omulecki A, Lesiak A, Narbutt J, Wozniacka A, Piekarski J, Biernat W","articleTitle":"Plaque form of warty dyskeratoma - acantholytic dyskeratotic acanthoma","bookWebsiteJournalTitle":"Journal of Cutaneous Pathology","date":"2007","volume":"34","pages":"494-496","url":"http://www.ncbi.nlm.nih.gov/pubmed/17518779","dateAccessed":"2012-03-26T00:00:00"},{"referenceId":5111,"authors":"Andrews BT, Trask DK","articleTitle":"Oral melanoacanthoma: a case report, a review of the literature, and a new treatment option","bookWebsiteJournalTitle":"The Annals of otology, rhinology, and laryngology","date":"2005","volume":"114","pages":"677-680","url":"http://www.ncbi.nlm.nih.gov/pubmed/16240929#","dateAccessed":"2012-03-26T00:00:00"}]},{"questionId":6083,"questionText":"How might an acanthoma be treated?","answerText":"Acanthomas are considered <a href=\"http://www.merriam-webster.com/medlineplus/benign\" target=_blank>benign</a>, but treatment may be done for cosmetic reasons or to relieve any associated symptoms.[5109][5111]&nbsp; Because acanthomas are quite rare, there are no established guidelines for treatment.&nbsp; Treatment may&nbsp;depend on the type, number, and location of acanthomas.&nbsp;&nbsp;For example,&nbsp;a single acanthoma&nbsp;may be&nbsp;removed by surgery, whereas multiple acanthomas may be treated with <a href=\"http://www.merriam-webster.com/medlineplus/cryosurgery\" target=_blank>cryosurgery</a> or the use of the medication <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a605010.html\" target=_blank>fluorouracil</a> cream.[5109]","dateModified":"2012-03-26T23:06:00","resourceClassificationName":"Treatment","references":[{"referenceId":5109,"authors":"Monari P, Farisoglio C, Gualdi G, Botali G, Ungari M, Calzavara-Pinton P","articleTitle":"Multiple eruptive clear cell acanthoma","bookWebsiteJournalTitle":"Journal of dermatological case reports","date":"2010","volume":"4","pages":"25-27","url":"http://www.ncbi.nlm.nih.gov/pubmed/21886743","dateAccessed":"2012-03-26T00:00:00"},{"referenceId":5111,"authors":"Andrews BT, Trask DK","articleTitle":"Oral melanoacanthoma: a case report, a review of the literature, and a new treatment option","bookWebsiteJournalTitle":"The Annals of otology, rhinology, and laryngology","date":"2005","volume":"114","pages":"677-680","url":"http://www.ncbi.nlm.nih.gov/pubmed/16240929#","dateAccessed":"2012-03-26T00:00:00"}]}]}],"news":[{"newsId":681,"dateCreated":"2020-11-30T12:27:00","publishDate":"2020-12-01T00:00:00","title":"NORD RareLaunchÂ® Workshops","description":"The National Organization for Rare Disorders is hosting&nbsp;RareLaunch&reg; Workshops on December 2 and 3. The workshops will provide useful information and hands-on training and advice from leading nonprofit experts to help launch a rare disease nonprofit or take an existing one to the next level.","url":"https://rarediseases.org/nord-rarelaunch/rarelaunch-workshops/","lastModified":"2020-11-30T13:00:00","isFeatured":false},{"newsId":677,"dateCreated":"2020-08-28T11:25:00","publishDate":"2020-09-01T00:00:00","title":"Rare Diseases Are Not Rare - Gallery of Creative Work Raises Awareness of Rare Diseases","description":"Participants nationwide showcased their creativity for the second Rare Diseases Are Not Rare! 2020 Challenge to raise awareness about rare diseases. NCATS selected 3 winners and 5 honorable mentions from an extraordinary gallery of submissions to a Challenge seeking creative ways to raise awareness about rare diseases and the importance of research.","url":"https://ncats.nih.gov/funding/challenges/rare-diseases-challenge-2020/winners","lastModified":"2020-09-03T13:44:00","isFeatured":false},{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false},{"newsId":672,"dateCreated":"2020-05-27T11:02:00","publishDate":"2020-05-21T00:00:00","title":"NCATS Translational Approach Addresses COVID-19","description":"NIH and NCATS are supporting many research activities to address the novel coronavirus 2019 (SARS-CoV-2) and the disease it causes (COVID-19). With the aim of accelerating translational research across all diseases, including rare diseases, NCATS has developed research tools, technologies, expertise and collaborative networks that can quickly pivot to address urgent public health issues. Find out more about how NCATS is using <a href=\"https://ncats.nih.gov/covid19-translational-approach\" target=\"_blank\">a translational approach to address COVID-19</a>.","url":"https://ncats.nih.gov/covid19-translational-approach","lastModified":"2020-05-28T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[]}